The combo has been granted Accelerated Approval in the US.
News
Setback for MedDay’s MD1003 as drug fails non-active progressive MS trial
MedDay will review the latest findings in detail “to understand these outcomes to help inform future clinical research in progressive MS and other neurological diseases.”
NICE hits Keytruda with ‘no’ for urothelial cancer
The rejection comes after a review of new evidence collected while the blockbuster was available via the Cancer Drugs Fund.
COVID-19: NHS ‘ramp up’ testing labs as outbreak declared pandemic
As well as testing of people who meet the criteria for being at risk, the NHS and PHE are also carrying out surveillance testing on people in wards and surgeries showing signs of the virus.
Empliciti, Revlimid combo falls short in multiple myeloma
BMS is “disappointed” at the outcome.
DE-122 flops in wet AMD trial
In a trial, the addition of DE-122 to Roche’s Lucentis (ranibizumab) did not improve visual acuity compared to treatment with Lucentis alone.
NICE, Health Technology Wales announce new partnership
The two organisations have detailed plans to work together on planning and information sharing over the assessment of medical technologies.
New genetic test could pick out ‘high risk’ bone marrow cancer patients
Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatment, enabling them to find alternative options as early as possible.
Final chance to enter into CROY 2020
The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Friday the 13th March.
Thrombocytopenia patients set to get Mulpleo after UK launch
The drug is the first licensed treatment available on the NHS in the UK to treat this condition.
Gene change could cause susceptibility to lung disease
The discovery could be the answer to why some people are more likely to develop a devastating lung disease – idiopathic pulmonary fibrosis (IPF).
ViiV, UNC-Chapel Hill renew HIV partnership for another five years
Since 2015, the first-of-its-kind collaboration has brought together academic and pharmaceutical industry researchers to create a deeper understanding of how HIV works.
Finalists announced for the 2020 International Clinical Researcher of the Year competition
Find out which individuals and teams will be putting their skills to the test in the live finals days later this year.
Breast cancer ‘breakthrough’ could end unnecessary biopsies
The novel mammography imaging system could potentially “spell an end” to unnecessary biopsies, by determining benign or malignant breast lesions.
EU Marketing Authorisation change for Maviret
The authorisation shortens the treatment period from from 12 to eight weeks.
